Results 101 to 110 of about 1,065,424 (332)

Privacy-by-Design Environments for Large-Scale Health Research and Federated Learning from Data. [PDF]

Int J Environ Res Public Health, 2022
Zhang P, Kamel Boulos MN.
europepmc   +1 more source

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan, John R. Mills, Paulina Vargas, Naveen K. Paramasivan, Connie E. Lesnick, Eati Basal, Surendra Dasari, James P. Fryer, Shannon R. Hinson, Joseph Laporta, Amy Espinal, Dennis Fitzgerald, Carolina Garcia, Anna E. Morenkova, Paola Pergami, Anna Shah, Andrew Knight, Reghann LaFrance Corey, Vanda A. Lennon, Anastasia Zekeridou, Sean J. Pittock, Divyanshu Dubey, Andrew McKeon   +22 more
wiley   +1 more source

On the Evaluation of Privacy Impact Assessment and Privacy Risk Assessment Methodologies: A Systematic Literature Review

IEEE Access
Assessing privacy risks and incorporating privacy measures from the onset requires a comprehensive understanding of potential impacts on data subjects. Privacy Impact Assessments (PIAs) offer a systematic methodology for such purposes, which are closely ...
Samuel Wairimu, Leonardo Horn Iwaya, Lothar Fritsch, Stefan Lindskog   +3 more
doaj   +1 more source

How Much User Context Do We Need? Privacy by Design in Mental Health NLP Application [PDF]

, 2022
Ramit Sawhney, Atula Tejaswi Neerkaje, Ivan Habernal, Lucie Flek   +3 more
openalex   +1 more source

Network Localization of Fatigue in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo, Jaakko Kungshamn, Albert Bellmunt‐Gil, Silvia Tommasin, Abhineet Ojha, Matias Viitala, Juho Aaltonen, Jyrki Lötjönen, Juha Koikkalainen, Pauli Ylikotila, Patrizia Pantano, Merja Soilu‐Hänninen, Juho Joutsa   +12 more
wiley   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

Use of a Value Model to Ethically Govern Various Applications of Small UAS

Drones, 2018
Widespread use of small unmanned aircraft systems is becoming prominent in the US. From structural health monitoring to journalism, small unmanned aerial systems (sUAS) are allowing people to gain a view of their surroundings and conduct their jobs in ...
Robert Philpott, Benjamin Kwasa, Christina Bloebaum   +2 more
doaj   +1 more source

PyFF: A Fog-Based Flexible Architecture for Enabling Privacy-by-Design IoT-Based Communal Smart Environments. [PDF]

Sensors (Basel), 2021
Benhamida FZ, Navarro J, Gómez-Carmona O, Casado-Mansilla D, López-de-Ipiña D, Zaballos A.   +5 more
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Smart cities, movilidad inteligente y protección de los datos personales

IDP, 2016
En este artículo, el autor afronta las cuestiones relativas a la protección de datos en el contexto de amplios proyectos de movilidad territorial. En la primera parte, se describen brevemente los sistemas de movilidad inteligente y los problemas que de ...
Alessandro Mantelero
doaj   +1 more source